drugset / Trial / NCT03022201

Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's Disease

NCT03022201

Phase 4 Completed 40 enrolled Seoul National University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the therapeutic efficacy and safety of DA-9701 with domperidone in patients with Parkinson's disease

Timeline

Start
2013-05
Primary completion
2016-05
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Domperidone Unknown 10 mg
Subject LUCORIDALINES Unknown 30 mg

Indications